Drug class
Interferon gamma; Lymphocyte Growth Factor
Mechanism of action
Canakinumab is a human monoclonal anti-human IL-1β antibody of the IgG1/κ isotype.
General use cases
- Arthritis, Juvenile
- Familial Mediterranean Fever
- Mevalonate Kinase Deficiency
- Cryopyrin-Associated Periodic Syndromes
- Tumor Necrosis Factor (TNF) Receptor Associated Periodic Syndrome (TRAPS) in adult and pediatric patients
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
